Vantage Pharmaceuticals Ltd
13095005
Healthy
- No accounts filed in last 18 months (-5)
Details
Compliance
Last accounts
31/12/2024
total exemption full
Next accounts due
30/09/2026
Confirmation statement
Last: 21/12/2025
Due 04/01/2027
Industry
Officers
director · Since 01/05/2022
PHARMACIST
BRITISH · ENGLAND · Age 41
Also on 3 other boards
Mr Christopher Blair Wagstaff
director · Since 07/08/2026
BRITISH · ENGLAND · Age 59
Former
director · Resigned 20/12/2023
director · Resigned 07/08/2026
Persons with Significant Control
Mrs Anne-Laure Marie Wagstaff
French,British · England · Age 47
Ravalco House, Cleveland Way, Hemel Hempstead, HP2 7DL
Notified 22/10/2021
Melissa Pricilla Raval
British · United Kingdom · Age 40
Ravalco House, Cleveland Way, Hemel Hempstead, HP2 7DL
Notified 22/10/2021
Former PSCs
Mr Robert Gaurav Singh Johal
Ceased 22/10/2021
Change History
Active
Private Limited Company
RAVALCO HOUSE
HEMEL HEMPSTEAD
CompanyRankvs 145+ SIC 21200 peers63
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£33k
Balance sheet strength
Cash
£480k
Cash in the bank
Net Current Assets
£33k
Working capital
Current Assets
£713k
Current Liabilities
£680k
Fixed Assets
£297
Debtors
£211k
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 1.05 | +£394k |
| 2023 | 0.47 | — |
Derived from filed accounts. Not audited figures.